Another HIV drug made by Israeli scientists has passed its first human clinical trial.
At end of the trial, it was found that the medication, named Gammora, made by Zion Medical, an Israeli biotech organization was fit for wiping out 99 percent of HIV infected cells in the human body.
As indicated by an announcement discharged by the organization and accessible on PR Newswire, Gammora could dispose of up to 90 percent of the infection amid the initial a month of the trial.
Zion Medical built up the medication Gammora in a joint effort with the Hebrew University in Jerusalem and the Sirion Biotech in Germany.
The medication is intended to assault and murder the HIV-contaminated cells in the human body without making any harm to the sound cells.
In the study, researchers randomly assigned nine participating patients from the Ronald Bata Memorial Hospital in Uganda to receive different doses of Gammora between four to five weeks in July and August of this year.
While the new HIV drug is still in its first stage of exploration, the results have already offered hope that a cure for the dreaded virus is possible.
“Most patients showed a significant reduction of the viral load of up to 90 per cent from the baseline during the first four weeks,” said Dr. Esmira Naftalim, Zion Medical’s head of development.